Home/PentixaPharm/Dr. Erik Merten
DE

Dr. Erik Merten

CTO

PentixaPharm

PentixaPharm Pipeline

DrugIndicationPhase
PentixaForPrimary Aldosteronism (Diagnostic)Phase 3
PentixaTherHemato-oncology (e.g., Multiple Myeloma, Lymphoma)Phase 1/2